About aspen pharmacare hld - APNHY
Aspen Pharmacare Holdings Ltd. manufactures and supplies branded and generic pharmaceutical products. It operates through the Commercial Pharmaceuticals and Manufacturing segments. The Commercial Pharmaceuticals segment consists of the following business sub segments: Sterile Focused Brands, which includes the Anaesthetics and Thrombosis portfolios; and Regional Brands, which are products that are managed on a regional basis. The Manufacturing segment focuses on the following business sub segments: Active Pharmaceutical Ingredients, which involved in API Chemicals business and non-heparin biochemical API business; Heparin, which refers to the full value chain contribution from all heparin containing products; FDF Steriles, which includes all FDF sterile sales; and FDF Other, which consists of all non-sterile FDF products. The company was founded by Michael Guy Attridge and Stephen Bradley Saad in 1850 and is headquartered in Durban, South Africa.
APNHY At a Glance
Aspen Pharmacare Holdings Ltd.
Aspen Place, 9 Rydall Vale Park
Durban, KwaZulu-Natal 4019
| Phone | 27-31-580-8600 | Revenue | 2.39B | |
| Industry | Pharmaceuticals: Major | Net Income | 235.34M | |
| Sector | Health Technology | 2024 Sales Growth | 4.297% | |
| Fiscal Year-end | 06 / 2025 | Employees | 9,350 | |
| View SEC Filings |
APNHY Valuation
| P/E Current | 16.974 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 24.117 |
| Price to Sales Ratio | 2.376 |
| Price to Book Ratio | 1.221 |
| Price to Cash Flow Ratio | 17.062 |
| Enterprise Value to EBITDA | 12.229 |
| Enterprise Value to Sales | 2.929 |
| Total Debt to Enterprise Value | 0.285 |
APNHY Efficiency
| Revenue/Employee | 255,504.883 |
| Income Per Employee | 25,169.854 |
| Receivables Turnover | 3.232 |
| Total Asset Turnover | 0.324 |
APNHY Liquidity
| Current Ratio | 1.808 |
| Quick Ratio | 1.07 |
| Cash Ratio | 0.506 |
APNHY Profitability
| Gross Margin | 41.648 |
| Operating Margin | 19.534 |
| Pretax Margin | 12.781 |
| Net Margin | 9.851 |
| Return on Assets | 3.196 |
| Return on Equity | 5.109 |
| Return on Total Capital | 3.542 |
| Return on Invested Capital | 4.016 |
APNHY Capital Structure
| Total Debt to Total Equity | 42.958 |
| Total Debt to Total Capital | 30.05 |
| Total Debt to Total Assets | 26.197 |
| Long-Term Debt to Equity | 29.626 |
| Long-Term Debt to Total Capital | 20.724 |